National Cancer Institute

FY 2016 Research Funding by Cancer Type

Cancer Type Funded Amount
Anus $4,555,603
Bladder $33,995,868
Brain $194,189,633
Breast $519,880,371
Buccal Cavity $15,083,195
Central Nervous System - Not Including Brain $2,146,351
Cervical Cancer $65,573,557
Childhood Leukemia $61,561,699
Colon/Rectum $212,173,293
Esophagus $26,226,485
Eye $4,986,202
Gallbladder $628,470
Head and Neck $58,924,503
Heart $1,290,739
Hodgkins disease $12,769,043
Kaposi Sarcoma $28,270,267
Kidney Cancer $41,837,803
Kidney Disease $43,443,841
Larynx $659,533
Leukemia $241,005,895
Liver Cancer $75,693,176
Lung $283,755,731
Melanoma $142,932,957
Multiple Myeloma $52,066,811
Nervous System $29,527,543
Neuroblastoma $19,959,764
Non Hodgkins Lymphoma $116,691,276
Ovarian Cancer $95,587,126
Pancreas $152,555,852
Parathyroid $619,234
Penis $648,979
Pharynx $3,017,232
Pituitary $1,760,629
Prostate $240,985,347
Salivary Glands $563,832
Sarcoma $77,110,724
Stomach $13,286,733
Testes $1,683,072
Thyroid $21,913,126
Urinary System $16,734,874
Uterine $16,839,480
Vaginal $508,111
Vascular Disease $1,459,037
Wilm's Tumor $4,529,967